Nuzenio

Fda Orphan Drug

Fda Orphan Drug news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 11 latest news signals 8 publisher sources 100/100 entity strength

Latest news

FDA grants orphan drug status to potential treatment for ALL - Rare Cancer NewsRare Cancer News · Fri, 07 Aug 2026 18:08:50 GMT Nieves Martinez Lago: FDA Grants Orphan Drug Designation to DLL3-Targeting ADC Zoci for NECs - OncodailyOncodaily · Fri, 07 Aug 2026 11:52:07 GMT Galibra Neuroscience Receives FDA Orphan Drug and Rare Pediatric Disease Designations for SSADH Deficiency Gene Therapy - PR NewswirePR Newswire · Thu, 06 Aug 2026 01:05:00 GMT FDA Names Zocilurtatug Pelitecan Orphan Drug in Neuroendocrine Carcinomas - Targeted OncologyTargeted Oncology · Wed, 05 Aug 2026 16:09:36 GMT FDA grants orphan drug designation to Zai Lab's zoci for neuroendocrine carcinomas - AllSciAllSci · Tue, 04 Aug 2026 12:20:33 GMT FDA Grants Orphan Drug Designation to Zocilurtatug Pelitecan for Neuroendocrine Carcinomas - OncLiveOncLive · Mon, 03 Aug 2026 15:59:22 GMT U.S. FDA Grants Orphan Drug Designation to Zai Lab’s DLL3-Targeting ADC Zocilurtatug Pelitecan (Zoci) for the Treatment of Neuroendocrine Carcinomas (NECs) - Business WireBusiness Wire · Mon, 03 Aug 2026 11:00:00 GMT Menin Inhibitor Enzomenib Gains FDA Orphan Drug Designation in ALL - Targeted OncologyTargeted Oncology · Fri, 31 Jul 2026 19:06:27 GMT

Timeline

Fri, 07 Aug 2026 18:08:50 GMTFDA grants orphan drug status to potential treatment for ALL - Rare Cancer News

Fri, 07 Aug 2026 11:52:07 GMTNieves Martinez Lago: FDA Grants Orphan Drug Designation to DLL3-Targeting ADC Zoci for NECs - Oncodaily

Thu, 06 Aug 2026 01:05:00 GMTGalibra Neuroscience Receives FDA Orphan Drug and Rare Pediatric Disease Designations for SSADH Deficiency Gene Therapy - PR Newswire

Wed, 05 Aug 2026 16:09:36 GMTFDA Names Zocilurtatug Pelitecan Orphan Drug in Neuroendocrine Carcinomas - Targeted Oncology

Tue, 04 Aug 2026 12:20:33 GMTFDA grants orphan drug designation to Zai Lab's zoci for neuroendocrine carcinomas - AllSci

Mon, 03 Aug 2026 15:59:22 GMTFDA Grants Orphan Drug Designation to Zocilurtatug Pelitecan for Neuroendocrine Carcinomas - OncLive

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Drug Designation8 live mentions FDA6 live mentions FDA Grants Orphan5 live mentions Neuroendocrine Carcinomas4 live mentions Zai Lab4 live mentions Treatment4 live mentions NECs3 live mentions Pulmonary Hypertension News3 live mentions ALL2 live mentions Targeting ADC Zoci2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Fda Orphan Drug.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.